Cargando…

Diagnostic Performance of Dengue Virus Envelope Domain III in Acute Dengue Infection

Dengue, one of the most prevalent illnesses caused by dengue viruses that are members of the genus Flavivirus, is a significant global health problem. However, similar clinical symptoms and high antigenic homologies with other Flaviviruses in the endemic area pose difficulties for differential diagn...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nguyen, Ngoc Minh, Duong, Bao Tuan, Azam, Mudsser, Phuong, Truong Thai, Park, Hyun, Thuy, Phung Thi Bich, Yeo, Seon-Ju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6679088/ https://www.ncbi.nlm.nih.gov/pubmed/31311082 http://dx.doi.org/10.3390/ijms20143464

Ejemplares similares

Addition of Partial Envelope Domain II into Envelope Domain III of Dengue Virus Antigen Potentiates the Induction of Virus-Neutralizing Antibodies and Induces Protective Immunity
por: Park, Jisang, et al.
Publicado: (2020)

Clinical and Virological Features of Dengue in Vietnamese Infants
por: Bich Chau, Tran Nguyen, et al.
Publicado: (2010)

Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III
por: Matsui, Kiyohiko, et al.
Publicado: (2010)

Dengue virus type-3 envelope protein domain III; expression and immunogenicity
por: Fahimi, Hossein, et al.
Publicado: (2014)

Molecular Changes in Dengue Envelope Protein Domain III upon Interaction with Glycosaminoglycans
por: Hyatt, James G., et al.
Publicado: (2020)

The value of daily platelet counts for predicting dengue shock syndrome: Results from a prospective observational study of 2301 Vietnamese children with dengue
por: Lam, Phung Khanh, et al.
Publicado: (2017)

Expression of an immunocomplex consisting of Fc fragment fused with a consensus dengue envelope domain III in Saccharomyces cerevisiae
por: So, Kum-Kang, et al.
Publicado: (2021)

The Association of Cytokines with Severe Dengue in Children
por: Mangione, Julia N.A., et al.
Publicado: (2014)

Production of dengue 2 envelope domain III in plant using CPMV - based vector system
por: Carlos Marques, Lívia Érika, et al.
Publicado: (2014)

Immunogenicity of a novel tetravalent dengue envelope protein domain III-based antigen in mice
por: Fahimi, Hossein, et al.
Publicado: (2018)

Corticosteroids for Dengue – Why Don't They Work?
por: Nguyen, Thi Hanh Tien, et al.
Publicado: (2013)

Immunogenic Subviral Particles Displaying Domain III of Dengue 2 Envelope Protein Vectored by Measles Virus
por: Harahap-Carrillo, Indira S., et al.
Publicado: (2015)

In silico binding analysis of lutein and rosmarinic acid against envelope domain III protein of dengue virus
por: Panchal, Ritesh, et al.
Publicado: (2021)

Households as Foci for Dengue Transmission in Highly Urban Vietnam
por: Anders, Katherine L., et al.
Publicado: (2015)

Genetic epidemiology of dengue viruses in phase III trials of the CYD tetravalent dengue vaccine and implications for efficacy
por: Rabaa, Maia A, et al.
Publicado: (2017)

DNA Vaccines against Dengue Virus Type 2 Based on Truncate Envelope Protein or Its Domain III
por: Azevedo, Adriana S., et al.
Publicado: (2011)

Casamino acids facilitate the secretion of recombinant dengue virus serotype-3 envelope domain III in Pichia pastoris
por: Kaushik, Neha, et al.
Publicado: (2016)

In silico analysis of an envelope domain III-based multivalent fusion protein as a potential dengue vaccine candidate
por: Fahimi, Hossein, et al.
Publicado: (2016)

Characterization of a Novel Dengue Serotype 4 Virus-Specific Neutralizing Epitope on the Envelope Protein Domain III
por: Ji, Guang-Hui, et al.
Publicado: (2015)

A broadly neutralizing germline-like human monoclonal antibody against dengue virus envelope domain III
por: Hu, Dan, et al.
Publicado: (2019)

Associations of obesity and dengue-associated mortality, acute liver failure and mechanical ventilation in children with dengue shock syndrome
por: Nguyen, Thanh Tat, et al.
Publicado: (2023)

Epidemiological and Clinical Features of Dengue Infection in Adults in the 2017 Outbreak in Vietnam
por: Huy, Bui Vu, et al.
Publicado: (2019)

Epidemiological Factors Associated with Dengue Shock Syndrome and Mortality in Hospitalized Dengue Patients in Ho Chi Minh City, Vietnam
por: Anders, Katherine L., et al.
Publicado: (2011)

Dengue-1 Envelope Protein Domain III along with PELC and CpG Oligodeoxynucleotides Synergistically Enhances Immune Responses
por: Chiang, Chen-Yi, et al.
Publicado: (2012)

Immunogenicity of a novel tetravalent vaccine formulation with four recombinant lipidated dengue envelope protein domain IIIs in mice
por: Chiang, Chen-Yi, et al.
Publicado: (2016)

Neutralizing Antibody Response and Efficacy of Novel Recombinant Tetravalent Dengue DNA Vaccine Comprising Envelope Domain III in Mice
por: Kulkarni, Ajit, et al.
Publicado: (2017)

Dengue Virus Envelope Protein Domain III Induces Nlrp3 Inflammasome-Dependent NETosis-Mediated Inflammation in Mice
por: Lien, Te-Sheng, et al.
Publicado: (2021)

Exposure to Dengue Envelope Protein Domain III Induces Nlrp3 Inflammasome-Dependent Endothelial Dysfunction and Hemorrhage in Mice
por: Lien, Te-Sheng, et al.
Publicado: (2021)

Development of clinical decision rules to predict recurrent shock in dengue
por: Huy, Nguyen Tien, et al.
Publicado: (2013)

Protective and Enhancing HLA Alleles, HLA-DRB1*0901 and HLA-A*24, for Severe Forms of Dengue Virus Infection, Dengue Hemorrhagic Fever and Dengue Shock Syndrome
por: Lan, Nguyen Thi Phuong, et al.
Publicado: (2008)

Sensitivity and Specificity of a Novel Classifier for the Early Diagnosis of Dengue
por: Tuan, Nguyen Minh, et al.
Publicado: (2015)

Serological inference of past primary and secondary dengue infection: implications for vaccination
por: Lam, Ha Minh, et al.
Publicado: (2019)

The Immunodominance Change and Protection of CD4(+) T-Cell Responses Elicited by an Envelope Protein Domain III-Based Tetravalent Dengue Vaccine in Mice
por: Chen, Hsin-Wei, et al.
Publicado: (2015)

An Evidence-Based Algorithm for Early Prognosis of Severe Dengue in the Outpatient Setting
por: Nguyen, Minh Tuan, et al.
Publicado: (2017)

Chimeric Hepatitis B core antigen virus-like particles displaying the envelope domain III of dengue virus type 2
por: Arora, Upasana, et al.
Publicado: (2012)

Simulation of Hemorrhage Pathogenesis in Mice through Dual Stimulation with Dengue Envelope Protein Domain III-Coated Nanoparticles and Antiplatelet Antibody
por: Lien, Te-Sheng, et al.
Publicado: (2023)

Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope
por: Metz, Stefan W., et al.
Publicado: (2018)

Dengue virus 4/2 envelope domain chimeric virus panel maps type-specific responses against dengue serotype 2
por: Zhu, Deanna R., et al.
Publicado: (2023)

Deep learning models for forecasting dengue fever based on climate data in Vietnam
por: Nguyen, Van-Hau, et al.
Publicado: (2022)

Development of a novel peptide aptamer-based immunoassay to detect Zika virus in serum and urine
por: Kim, Do Thi Hoang, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_si3kmgdmh097p8078qq3pe0ffu